Northwest Biotherapeutics reported $311K in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Agenus USD 22.44M 1.14M Dec/2025
AstraZeneca USD 17.88B 1.17B Mar/2026
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Celldex Therapeutics USD 230K 1.78M Mar/2026
Eisai JPY 227B 22.05B Mar/2026
Merck USD 11.78B 345M Dec/2025
Northwest Biotherapeutics USD 311K 299K Sep/2025
Pfizer USD 16.17B 332M Mar/2026
Plus Therapeutics USD 322K 699K Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025